EUVIMEDEUVIMED entdecken
Crossref

Noninvasive Transdermal Administration of mRNA Vaccines Encoding Multivalent Neoantigens Effectively Inhibits Melanoma Growth

Yuting Hou, Zhe Wang, Zhen Chen, Lan Shuai, Yifei Pei, Binbin Sun, Yuxin Jiang, Hongsheng Wang iD

ACS Biomaterials Science & Engineering · 08.07.2024 · 10 (7) · 4587-4600

DOI: 10.1021/acsbiomaterials.4c00426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 13.06.2024. Verfasst von Yuting Hou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua U…. Hauptthemen laut MEDLINE: Cancer Vaccines, Administration, Cutaneous, mRNA Vaccines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, the Municipal Public Welfare Research Project from Jiaxing, Zhejiang Province, Medicine-Engineering Interdisciplinary Project of Shanghai Xuhui District Dental Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is difficult to obtain specific tumor antigens, which is one of the main obstacles in the development of tumor vaccines. The vaccines containing multivalent antigens are thought to be more effective in antitumor therapy. In this study, a mRNA encoding three neoantigens of melanoma were prepared and encapsulated into the mannosylated chitosan-modified ethosomes (EthsMC) to obtain a multivalent mRNA vaccine (MmRV) for transcutaneous immunization (TCI). MmRV can effectively induce maturation of dendritic cells, with a better performance than mRNA of a single neoantigen. TCI patches (TCIPs) loading MmRV or siRNA against PDL1 (siPDL1) were prepared and applied to the skin of melanoma-bearing mice. The results showed that TCIPs significantly increase the levels of TNF-α, IFN-γ, and IL-12 in both plasma and tumor tissues, inhibit tumor growth, as well as promote infiltration of CD4+ and CD8+ T cells in the tumor tissues. Furthermore, the combination of MmRV and siPDL1 showed much better antitumor effects than either monotherapy, suggesting a synergistic effect between the vaccine and PDL1 blocker. In addition, the treatment with the TCIPs did not cause damage to the skin, blood, and vital organs of the mice, showing good biosafety. To the best of our knowledge, this work is the first to construct a noninvasive TCI system containing MmRV and siPDL1, providing a convenient and promising approach for tumor treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesAdministration, CutaneousmRNA VaccinesAnimalsMiceAntigens, NeoplasmMice, Inbred C57BLFemaleMelanomaChitosanMelanoma, ExperimentalCell Line, TumorRNA, MessengerSkin NeoplasmsCD8-Positive T-Lymphocytes

Stichwörter der Autor:innen

PDL1RNA therapydendritic cellsmelanomamultivalent antigenstranscutaneous immunization vaccine

Substanzen

Cancer VaccinesmRNA VaccinesAntigens, NeoplasmChitosanRNA, Messenger

Autor:innen und Institutionen

  • Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua University, Shanghai 201620, China.
  • Xuhui District Dental Disease Prevention and Treatment Institute, Shanghai 200030, China.
  • The First Hospital of Jiaxing, Jiaxing Key Laboratory of Virus-related Infectious Diseases, Jiaxing University, Jiaxing 314001, China.

ORCID-Profile: Hongsheng Wang

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • the Municipal Public Welfare Research Project from Jiaxing, Zhejiang Province
  • Medicine-Engineering Interdisciplinary Project of Shanghai Xuhui District Dental Center
  • Open Project Program of Jiaxing Key Laboratory of Virus-related Infectious Diseases

Zitieren

APA

Hou, Y., Wang, Z., Chen, Z., Shuai, L., Pei, Y., Sun, B., Jiang, Y., & Wang, H. (2024). Noninvasive Transdermal Administration of mRNA Vaccines Encoding Multivalent Neoantigens Effectively Inhibits Melanoma Growth. ACS Biomaterials Science & Engineering, 10(7), 4587-4600. https://doi.org/10.1021/acsbiomaterials.4c00426

Vancouver

Hou Y, Wang Z, Chen Z, Shuai L, Pei Y, Sun B, et al. Noninvasive Transdermal Administration of mRNA Vaccines Encoding Multivalent Neoantigens Effectively Inhibits Melanoma Growth. ACS Biomaterials Science & Engineering. 2024;10(7):4587-4600. doi:10.1021/acsbiomaterials.4c00426

BibTeX
@article{Hou2024,
  author = {Hou, Yuting and Wang, Zhe and Chen, Zhen and Shuai, Lan and Pei, Yifei and Sun, Binbin and Jiang, Yuxin and Wang, Hongsheng},
  title = {Noninvasive Transdermal Administration of mRNA Vaccines Encoding Multivalent Neoantigens Effectively Inhibits Melanoma Growth},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2024},
  volume = {10},
  number = {7},
  pages = {4587--4600},
  doi = {10.1021/acsbiomaterials.4c00426}
}
Kostenlos starten →